These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Model systems for the discovery and development of antiarrhythmic drugs. Nattel S, Duker G, Carlsson L. Prog Biophys Mol Biol; 2008 Nov; 98(2-3):328-39. PubMed ID: 19038282 [Abstract] [Full Text] [Related]
6. Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: a prospective study in patients with dilated cardiomyopathy. Sakabe K, Ikeda T, Sakata T, Kawase A, Kumagai K, Tezuka N, Takami M, Nakae T, Noro M, Enjoji Y, Sugi K, Yamaguchi T. Ann Noninvasive Electrocardiol; 2001 Jul; 6(3):203-8. PubMed ID: 11466138 [Abstract] [Full Text] [Related]
13. Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs. Woosley RL, Roden DM. Am J Cardiol; 1987 Apr 30; 59(11):19E-25E. PubMed ID: 3554949 [Abstract] [Full Text] [Related]
14. Electrophysiologic evaluation of antiarrhythmic drugs. Touboul P. Cardiovasc Drugs Ther; 1990 Jun 30; 4 Suppl 3():535-9. PubMed ID: 2275885 [Abstract] [Full Text] [Related]
15. Hopes and disappointments with antiarrhythmic drugs. Camm AJ. Int J Cardiol; 2017 Jun 15; 237():71-74. PubMed ID: 28365182 [Abstract] [Full Text] [Related]